IL151772A0 - Methods for producing pneumococcal capsular polysaccharide - Google Patents

Methods for producing pneumococcal capsular polysaccharide

Info

Publication number
IL151772A0
IL151772A0 IL15177201A IL15177201A IL151772A0 IL 151772 A0 IL151772 A0 IL 151772A0 IL 15177201 A IL15177201 A IL 15177201A IL 15177201 A IL15177201 A IL 15177201A IL 151772 A0 IL151772 A0 IL 151772A0
Authority
IL
Israel
Prior art keywords
methods
capsular polysaccharide
pneumococcal capsular
test compound
producing
Prior art date
Application number
IL15177201A
Other languages
English (en)
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL151772(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Publication of IL151772A0 publication Critical patent/IL151772A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL15177201A 2000-03-16 2001-03-16 Methods for producing pneumococcal capsular polysaccharide IL151772A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (fr) 2000-03-16 2001-03-16 Modulation de la production de polysaccharides capsulaires de pneumocoques

Publications (1)

Publication Number Publication Date
IL151772A0 true IL151772A0 (en) 2003-04-10

Family

ID=22699002

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15177201A IL151772A0 (en) 2000-03-16 2001-03-16 Methods for producing pneumococcal capsular polysaccharide
IL151772A IL151772A (en) 2000-03-16 2002-09-15 Processes for the preparation of a phenococcal capsular polysaccharide
IL191962A IL191962A (en) 2000-03-16 2008-06-05 Method for assessing if a test compound is useful for alleviating a pneumococcal infection

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL151772A IL151772A (en) 2000-03-16 2002-09-15 Processes for the preparation of a phenococcal capsular polysaccharide
IL191962A IL191962A (en) 2000-03-16 2008-06-05 Method for assessing if a test compound is useful for alleviating a pneumococcal infection

Country Status (19)

Country Link
US (1) US6642017B2 (fr)
EP (2) EP1268844B1 (fr)
JP (1) JP4856345B2 (fr)
KR (3) KR100942738B1 (fr)
CN (2) CN100529054C (fr)
AT (1) ATE437955T1 (fr)
AU (2) AU4579501A (fr)
BR (1) BRPI0109293B8 (fr)
CA (1) CA2403001C (fr)
CY (1) CY1109418T1 (fr)
DE (1) DE60139384D1 (fr)
DK (1) DK1268844T3 (fr)
ES (1) ES2330919T3 (fr)
HK (1) HK1055448A1 (fr)
IL (3) IL151772A0 (fr)
MX (1) MXPA02009047A (fr)
NZ (1) NZ521343A (fr)
PT (1) PT1268844E (fr)
WO (1) WO2001068903A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642017B2 (en) * 2000-03-16 2003-11-04 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide
PL3466982T3 (pl) * 2005-04-08 2020-11-02 Wyeth Llc Usuwanie zanieczyszczeń z polisacharydu streptococcus pneumoniae poprzez zmianę ph
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
WO2008045852A2 (fr) * 2006-10-10 2008-04-17 Wyeth Procédés améliorés pour la séparation de polysaccharides du type 3 de streptococcus pneumoniae
WO2009059054A2 (fr) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Souches de bactéries et bactériocine produite à partir de celles-ci
DK2385981T3 (da) * 2008-12-18 2019-10-21 Wyeth Llc Fremgangsmåde til kontrol af molekylvægt af streptococcus pneumoniae-polysaccharid ved anvendelse af carbon
MX2011006432A (es) * 2008-12-18 2011-09-29 Wyeth Llc Metodo para controlar el peso molecular del polisacarido streptococcus pneumoniae serotipo 19a.
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
EP3140414B1 (fr) 2014-05-07 2022-10-26 GlaxoSmithKline Biologicals S.A. Purification de polysaccharides sécrétées provenant de s. agalactiae
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
JP6701168B2 (ja) 2014-07-31 2020-05-27 コーニング インコーポレイテッド 熱強化ガラス、ならびにガラスの熱強化のための方法および装置
JP6923555B2 (ja) 2016-01-12 2021-08-18 コーニング インコーポレイテッド 薄厚熱強化及び化学強化ガラス系物品
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
CN111065609A (zh) 2017-08-24 2020-04-24 康宁股份有限公司 具有改进的回火能力的玻璃
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
CN111630153A (zh) * 2018-01-22 2020-09-04 一般财团法人阪大微生物病研究会 用于培养肺炎球菌样品的培养基
WO2021025981A1 (fr) 2019-08-06 2021-02-11 Corning Incorporated Stratifié de verre ayant des pointes de contrainte enfouies pour arrêter les fissures et procédés de fabrication associé

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (fr) * 1993-04-20 1994-10-21 David E. Briles Regions epitopiques de la proteine pneumococcique de surface a
EP0804582A1 (fr) * 1994-05-16 1997-11-05 The Uab Research Foundation GENES DE POLYSACCHARIDE CAPSULAIRE DE $i(STREPTOCOCCUS PNEUMONIAE)ET LEURS REGIONS D'ENCADREMENT
US6642017B2 (en) * 2000-03-16 2003-11-04 The Children's Hospital Of Philadelphia Modulating production of pneumococcal capsular polysaccharide

Also Published As

Publication number Publication date
KR20080036656A (ko) 2008-04-28
AU4579501A (en) 2001-09-24
KR20030040196A (ko) 2003-05-22
EP1967591A2 (fr) 2008-09-10
EP1268844A4 (fr) 2006-03-29
PT1268844E (pt) 2009-11-03
BR0109293A (pt) 2003-06-10
CA2403001A1 (fr) 2001-09-20
JP4856345B2 (ja) 2012-01-18
CN1429276A (zh) 2003-07-09
BRPI0109293B8 (pt) 2021-05-25
NZ521343A (en) 2005-03-24
DK1268844T3 (da) 2009-11-16
KR20080081978A (ko) 2008-09-10
IL191962A (en) 2010-12-30
EP1268844A1 (fr) 2003-01-02
KR100914702B1 (ko) 2009-08-28
EP1967591A3 (fr) 2008-12-03
US6642017B2 (en) 2003-11-04
DE60139384D1 (de) 2009-09-10
CN100529054C (zh) 2009-08-19
MXPA02009047A (es) 2005-04-19
US20030021811A1 (en) 2003-01-30
HK1055448A1 (en) 2004-01-09
ATE437955T1 (de) 2009-08-15
CN101586143A (zh) 2009-11-25
JP2003531584A (ja) 2003-10-28
AU2001245795B2 (en) 2005-07-28
BRPI0109293B1 (pt) 2015-05-19
KR100942738B1 (ko) 2010-02-17
IL151772A (en) 2009-12-24
CY1109418T1 (el) 2014-08-13
EP1268844B1 (fr) 2009-07-29
ES2330919T3 (es) 2009-12-17
IL191962A0 (en) 2008-12-29
WO2001068903A1 (fr) 2001-09-20
CA2403001C (fr) 2012-07-03

Similar Documents

Publication Publication Date Title
IL151772A0 (en) Methods for producing pneumococcal capsular polysaccharide
AR248168A1 (es) Metodo y aparato para producir un tetrasacarido y alimento que lo comprende.
DE68923932D1 (de) Hauttest und Testkit für AIDS.
NO894367L (no) System og fremgangsmaate for kvantitativ bestemmelse av konsentrasjonene av flere gasser i boreslam.
TR200000338T2 (tr) Polietilen'in hazırlanmasına mahsus bir yöntem.
HK124293A (en) Diagnostic kit and method for rapid detection of antibodies
DE122011100030I1 (de) Polyribosylribitol-phosphat enthaltende Haemophilus-influenzae-Typ -b-Impfstoffzubereitung und Verfahren zur deren Herstellung.
ATE80524T1 (de) Gefrorenes produkt und herstellungsverfahren.
MX9707875A (es) Levobupivacaina y su uso como un anestesico en mujeres embarazadas.
SE9501808D0 (sv) New process
BR0114403A (pt) Polipeptìdeos de "haemophilus influenzae" que podem ser usados para fins de profilaxia, diagnóstico e/ou terapia
DE3873128D1 (de) Verfahren zur herstelung eines elektrischen uebertragungslinie.
EP0761686A3 (fr) Dérivés du facteur Va anticoagulant
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
DE3689855D1 (de) Rhizobium-Impfstoffe.
DK0809653T3 (da) Helicobacter pylori-antigen
GB8906796D0 (en) Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions
UA49675A (uk) Спосіб лікування орнітозної пневмонії
RU2002133737A (ru) Способ лечения бруцеллеза, включающий пероральное применение иммуномодулятора, иммобилизованного в липосому
UA33944A (uk) Спосіб інтраопераційної рн-метрії
UA41128A (uk) Спосіб діагностики літогенності жовчі
UA38876A (uk) Спосіб профілактики ускладнень віддалених нейропатій, викликаних нейропаралітичними фосфороорганічними речовинами